Innealta Capital’s OrthoPediatrics KIDS Stock Holding History

Innealta Capital’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4	Closed	-$115	–	954
2024 Q2	$115	Buy	+4	New	+$123	﹤0.01%	1665

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Innealta Capital's KIDS Position: Q3 2024 in Review

Innealta Capital sold out of OrthoPediatrics (KIDS) in Q3 2024, closing a stake of 4 shares — an estimated $115 sold.

Innealta Capital first reported a position in KIDS in Q2 2024 and held it in 1 quarter. The position peaked at $115 in Q2 2024. 124 funds tracked by Wall St. Rank hold KIDS as of Q3 2024.

Innealta Capital reported no remaining OrthoPediatrics position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 4 OrthoPediatrics shares in Q3 2024, an estimated $115.
Innealta Capital first reported a position in OrthoPediatrics in Q2 2024 and held it in 1 quarter.
Innealta Capital's OrthoPediatrics position peaked at $115 in Q2 2024.
124 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.